SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-21-027868
Filing Date
2021-04-21
Accepted
2021-04-21 19:00:45
Documents
1
Period of Report
2021-04-19

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 33018
  Complete submission text file 0001209191-21-027868.txt   35002
Mailing Address 120 WEST FORTY-FIFTH STREET 39TH FLOOR NEW YORK NY 10036
Business Address
SHAW DAVID E (Reporting) CIK: 0001023870 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-39206 | Film No.: 21842778

Mailing Address 120 WEST 45TH STREET 17TH FLOOR NEW YORK NY 10036
Business Address 120 WEST 45TH STREET 17TH FLOOR NEW YORK NY 10036 503-299-1150
Schrodinger, Inc. (Issuer) CIK: 0001490978 (see all company filings)

IRS No.: 954284541 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 120 WEST 45TH STREET, 39TH FLOOR NEW YORK NY 10036
Business Address 120 WEST 45TH STREET, 39TH FLOOR NEW YORK NY 10036 (212) 403-8007
Schrodinger Equity Holdings, LLC (Reporting) CIK: 0001801739 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-39206 | Film No.: 21842777